Skip to content

A Study on the effectiveness of selected panchkarma procedures in the management of facial nerve pain

An Open Label clinical trial to evaluate the efficacy of selected Panchkarma Procedures in the management of Anantvata with special reference to Trigeminal Neuralgia - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102208
Enrollment
30
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G09- Sequelae of inflammatory diseasesof central nervous system

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 40-60yrs Paroxysmal attacks of pain lasting from a fraction of a second to 2 min affecting one or more divisions of the trigeminal nerve. Pain has at least one of the following characteristics Intense, sharp, superficial or stabbing Precipitated from trigger areas or by trigger factors. Attacks are stereotyped in the individual patient. Patients having clinical signs and symptoms of Anantvata like Manyapaschad ghatasu vednam (pain in sternomastoid region and at the back of neck) Spandnam gandasyaparshwa(throbbing pain in sides of cheeks) Netraroga(eye diseases) Hanugreham (lock jaw) Tivra kurvati akshibrhushankhevavtishthe (Pain in eyes and along the eyebrows)

Exclusion criteria

Exclusion criteria: Having undergone Trigeminal Neuralgia-related surgical treatment. Having a clear history of neurological diseases such as brain trauma, Cerebral Hemorrhage, or Brain Tumors. Patients with a history or risk of seizures or a history of Epilepsy, Head injury or related Neurological disorders. Patients with a history of poorly controlled and uncontrolled Hypertension (above150/100 mm of Hg) Pregnant and Lactating women

Design outcomes

Primary

MeasureTime frame
Changes in Visual Analog Score.Timepoint: Changes in Visual Analog Score.

Secondary

MeasureTime frame
Changes in sign and symptoms of Anantvata. Changes in HADS Scale. Timepoint: - Continuous monitoring throughout the study Specific assessments on Day 0, Day 15, Day 30

Countries

India

Contacts

Public ContactProfessor Dr Gopesh Mangal

National Institute of Ayurveda

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026